Y ahora...tambien GLAXO

The cuts by Glaxo, the world's second largest drugs company after U.S. group Pfizer (nyse: PFE - news - people ), are part of Chief Executive Andrew Witty's strategy to meet the challenges facing the industry, including increased competition from generic drug makers, the British newspaper said.

Mas...